{"product_id":"pharmacogenomics-in-drug-discovery-and-development-9781071625729","title":"Pharmacogenomics in Drug Discovery and Development","description":"\u003cp\u003e\u003cb\u003e1. Target Discovery for Drug Development Using Mendelian Randomization\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Daniel S. Evans\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003e2. Human Leukocyte Antigen (HLA) Testing in Pharmacogenomics\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Ann M. Moyer and Manish J. Gandhi\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003e3. Pharmacogenomics in Targeted Therapy and Supportive Care Therapies for Cancer\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Zahra Talebi, Alex Sparreboom, and Susan I. Colace\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003e4. Pharmacogenomics in Cytotoxic Chemotherapy of Cancer\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Zahra Talebi, Alex Sparreboom, and Susan I. Colace\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003e5. Management of Side Effects in the Personalized Medicine Era: Chemotherapy-Induced Peripheral Neuropathy\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Eleonora Pozzi and Paola Alberti\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003e6. The Yin-Yang Dynamics in Cancer Pharmacogenomics and Personalized Medicine\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Qing Yan\u003c\/p\u003e \u003cp\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7. Design of Personalized Neoantigen RNA Vaccines Against Cancer Based on Next Generation Sequencing Data\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Begoña Alburquerque-González, María Dolores López-Abellán, Ginés Luengo-Gil, Silvia Montoro-García, and Pablo Conesa-Zamora\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003e8. COVID-19 Pharmacotherapy: Drug Development, Repurposing of Drugs, and the Role of Pharmacogenomics\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Rebecca Bock, Mariana Babayeva, and Zvi G. Loewy\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003e9. Pharmacogenomics Informs Cardiovascular Pharmacotherapy\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Mariana Babayeva, Brigitte Azzi, and Zvi G. Loewy\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003e10. Pharmacogenomic Screening of Patient-Specific hiPSC-Derived Cardiomyocyte Drug Candidates Using High-Throughput Calcium Imaging\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Malorie Blancard, K. Ashley Fetterman, and Paul W. Burridge\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003e11. The Yin-Yang Dynamics in Cardiovascular Pharmacogenomics and Personalized Medicine\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Qing Yan\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003e12. GTP\u003c\/b\u003e\u003cb\u003egS Assay for Measuring Agonist-Induced Desensitization of Two Human Polymorphic Alpha\u003csub\u003e2B\u003c\/sub\u003e-Adrenoceptor Variants\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Jordana I. Borges, Alexandra M. Carbone, Natalie Cora, Anastasiya Sizova, and Anastasios Lymperopoulos\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003e13. Pharmacogenomics of Alzheimer's Disease: Novel Strategies for Drug Utilization and Development\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Ramón Cacabelos, Vinogran Naidoo, Olaia Martínez-Iglesias, Lola Corzo, Natalia Cacabelos, Rocío Pego, and Juan C. Carril\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003e14. Pharmacogenetics of Antipsychotic Treatment in Schizophrenia\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Samar S.M. Elsheikh, Daniel J. Müller, and Jennie G. Pouget\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003e15. The Pharmacogenetic Impact on the Pharmacokinetics of ADHD Medications\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Jacob T. Brown\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003e16. Pharmacogenetics of Addiction Therapy\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e David P. Graham, Mark J. Harding, and David A. Nielsen\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003e17. Pharmacogenomics of Opioid Treatment for Pain Management\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e \u0026amp;nb\u003cbr\u003e\u003cbr\u003e\u003cb\u003eAuthor:\u003c\/b\u003e Qing Yan\u003cbr\u003e\u003cb\u003ePublisher:\u003c\/b\u003e Humana\u003cbr\u003e\u003cb\u003ePublished:\u003c\/b\u003e 09\/07\/2022\u003cbr\u003e\u003cb\u003ePages:\u003c\/b\u003e 616\u003cbr\u003e\u003cb\u003eBinding Type:\u003c\/b\u003e Hardcover\u003cbr\u003e\u003cb\u003eWeight:\u003c\/b\u003e 2.87lbs\u003cbr\u003e\u003cb\u003eSize:\u003c\/b\u003e 10.00h x 7.00w x 1.38d\u003cbr\u003e\u003cb\u003eISBN:\u003c\/b\u003e 9781071625729\u003c\/p\u003e\u003cp\u003e\u003ci\u003eThis title is not returnable\u003c\/i\u003e\u003cbr\u003e\u003c\/p\u003e","brand":"Humana","offers":[{"title":"Hardcover","offer_id":41015537533043,"sku":"9.78107E+12","price":373.57,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0555\/9255\/0515\/products\/img_c08ee608-b8c0-4454-8c72-beddfcb06994.jpg?v=1697559162","url":"https:\/\/bookstorenmore.com\/products\/pharmacogenomics-in-drug-discovery-and-development-9781071625729","provider":"Bookstore N More","version":"1.0","type":"link"}